Global Anaesthesia Drugs Market Report and Forecast 2024-2032

Global Anaesthesia Drugs Market Outlook

The global anaesthesia drugs market stood at a value of nearly USD 6.08 billion in 2023. The market is further expected to grow at a CAGR of 4.2% in the forecast period of 2024-2032 to attain a value of almost USD 8.81 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Use of Local Drugs to Augment the Global Anaesthesia Drugs Industry

On the basis of drug type, the local drug segment accounted for a significant share in the market and is anticipated to witness a steady growth over the forecast period. The growth can be attributed to the rising demand for local drugs in various applications, particularly dental surgeries. The anticipated increase in minor procedures such as filling or wisdom tooth removal is expected to bolster the demand for local anaesthetics. Meanwhile, the growing awareness about the benefits of general drugs, which include reduced intraoperative patient awareness and complete control of the airway, breathing and circulation, among others, is expected to aid the growth of the segment.

Based on the route of administration, the inhalation segment is likely to account for a significant share in the market owing to the cost-effectiveness of the method and its precise control over the anaesthetic state. Also, the inhaled anaesthetics have a low solubility in the blood and tissues, possess a protective effect and are resistant to physical and metabolic degradation, thus, further contributing to the demand growth.

North America Accounts for a Significant Share in the Global Anaesthesia Drugs Industry

North America, due to rapid technological advancements and the high healthcare expenditure, accounts for a considerable share in the market. The region is further expected to be aided by the increasing number of surgeries in countries like the United States and Canada. Meanwhile, Europe and the Asia Pacific are likely to grow at a significant rate in the forecast period owing to the ongoing healthcare reforms in the regions. The increasing focus to improve access to healthcare facilities in emerging countries of the Asia Pacific is expected to significantly contribute to the market growth in the forecast period.

Anaesthesia Drugs: Market Segmentation

Anaesthesia can be defined as the use of medicines to prevent pain during a medical procedure. Thus, the combination of medications that put a person in a sleep-like state before a surgery or some other medical procedure is known as anaesthetic drug. Anaesthetic drugs are used to ensure that a patient is in a completely unconscious state so that he/she does not feel any kind of pain.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on route of administration, the market is divided into:

• Inhalation

• Injection

• Others

On the basis of drug type, the industry is segmented into:

• General Drug

• Local Drug

While the general drug segment is further divided into propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others, the local drug segment is further categorised into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others.

The significant applications of the product are:

• General Surgery

• Plastic Surgery

• Cosmetic Surgery

• Dental Surgery

• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Prevalence of Gastrointestinal Diseases to Boost the Growth of the Anaesthesia Drugs Industry

The global anaesthesia drugs industry is driven by the rising prevalence of gastrointestinal diseases, such as gastroesophageal disease, liver cirrhosis, pancreatitis, and inflammatory bowel disease, among others. These diseases require intense surgery to attack the root of the disease, therefore, appropriate anaesthesia is needed for the safety of the patients. In addition, the easy availability of local drugs and the increasing hospitalisation rates are significantly contributing to the market growth. Over the forecast period, the market is expected to be aided by the rapid advancements in the healthcare industry.

Key Industry Players in the Global Anaesthesia Drugs Market

The report gives a detailed analysis of the following key players in the global anaesthesia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Pfizer Inc.

• Fresenius SE & Co. KGaA

• Baxter International, Inc.

• AbbVie Inc.

• B. Braun Melsungen AG

• Piramal Enterprises Limited

• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report